Barclays Maintains an 'Equalweight' on Omnicare (OCR); New CEO, Come on Down

September 10, 2012 2:46 PM EDT Send to a Friend
Get Alerts OCR Hot Sheet
Price: $46.23 +1.18%

Rating Summary:
    2 Buy, 4 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 11 | Down: 35 | New: 23
Trade OCR Now!
Barclays maintains an 'Equalweight' on Omnicare (NYSE: OCR) price target of $37.00.

Analyst, Lawrence C. Marsh, expects the company to formally announce the name of a new CEO this week. Currently, Marsh believes that interim CEO, current President/CFO, John Workman is the leading candidate. A confirmation would be viewed constructively.

Workman is well respected and the markets should view that announcement positively. At the same time, a possible stock buyback announcement (along with a normal dividend declaration) would be additional boost to the share price.

For an analyst ratings summary and ratings history on Omnicare click here. For more ratings news on Omnicare click here.

Shares of Omnicare closed at $33.44 yesterday, with a 52 week range of $20.36-$36.48.


Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here



You May Also Be Interested In


Related Categories

Analyst Comments, Dividends, Management Changes, Stock Buybacks

Related Entities

Barclays, Dividend, Stock Buyback

Add Your Comment